Abstract: Described are methods of treating viral disease using compounds that block inhibitory NK cell receptors, thereby reducing their inhibition of NK cell cytotoxicity in killing infected target cells. In one embodiment, the compound is an antibody binding, for example, one or more of the human KIR2DL1, KIR2DL2, and KIR2DL3 receptors. In another embodiment, the method further comprises administering a therapeutic antibody or fusion protein which binds an antigen expressed on cells infected with the virus.
Type:
Grant
Filed:
October 1, 2013
Date of Patent:
May 10, 2016
Assignees:
Innate Pharma S.A.S., Novo Norkisk A/S
Inventors:
Peter Andreas Nicolai Reumert Wagtmann, Francois Romagne, Joakim Glamann
Abstract: Described are methods of treating viral disease using compounds that block inhibitory NK cell receptors, thereby reducing their inhibition of NK cell cytotoxicity in killing infected target cells. In one embodiment, the compound is an antibody binding, for example, one or more of the human KIR2DL1, KIR2DL2, and KIR2DL3 receptors. In another embodiment, the method further comprises administering a therapeutic antibody or fusion protein which binds an antigen expressed on cells infected with the virus.
Type:
Application
Filed:
October 1, 2013
Publication date:
January 23, 2014
Applicants:
Innate Pharma S.A.S., Novo Norkisk A/S
Inventors:
Peter Andreas, Nicolai, Reumert WAGTMANN, Francois ROMAGNE, Joakim GLAMANN
Abstract: The present invention relates to an apparatus for analysing beads and particles, such as polymer beads used e.g. for solid phase synthesis. The apparatus comprises a) a vacuum container comprising at least one planar capture body capable of rotating around a central axis, wherein said capture body comprises a plurality of through-going inlets, and wherein the diameter of each inlet is smaller than the average diameter of the beads to be measured and/or analysed and/or sorted, b) a pressure controlling device capable of controlling the pressure in the vacuum container, c) a device for rotating the vacuum container around the axis of the capture body, and d) a device for measuring at least one property of at least one bead, the apparatus further comprising a capture body support, supporting the capture body, and a vacuum container housing.
Abstract: Insulin derivatives in which one or more of the four amino acid residues of positions A4, A17, B13 and B21 comprise an uncharged side chain and pharmaceutical preparations containing these insulin derivatives.